Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients

BACKGROUND: The methylated septin 9 (mSEPT9) assay was the first blood-based test approved by the United States Food and Drug Administration as a colorectal screening test. However, the diagnostic and prognostic role of preoperative mSEPT9 for colorectal cancer (CRC) in Chinese patients is still unk...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, Xu, Zhi-Jie, Chen, Xi, Zeng, Shuang-Shuang, Qian, Long, Wei, Jie, Peng, Mei, Wang, Xiang, Liu, Wan-Li, Ma, Hong-Ying, Gong, Zhi-Cheng, Yan, Yuan-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506579/
https://www.ncbi.nlm.nih.gov/pubmed/31114136
http://dx.doi.org/10.3748/wjg.v25.i17.2099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506579/
https://www.ncbi.nlm.nih.gov/pubmed/31114136
http://dx.doi.org/10.3748/wjg.v25.i17.2099

Ejemplares similares